Preferred Label : Spastic paraplegia 5a, autosomal recessive;
Symbol : SPG5A;
CISMeF acronym : SPG5A;
Type : Phenotype, molecular basis known;
Description : The hereditary spastic paraplegias (SPG) are a group of clinically and genetically
diverse disorders characterized by progressive, usually severe, lower extremity spasticity;
see reviews of Fink et al. (1996) and Fink (1997). Inheritance is most often autosomal
dominant (see 182600), but X-linked (see 303350) and autosomal recessive forms also
occur. Autosomal recessive forms of SPG include SPG7 (607259), caused by mutation
in the paraplegin gene (602783) on chromosome 16q24; SPG11 (604360), caused by mutation
in the spatacsin gene (610844) on 15q21; SPG15 (270700), caused by mutation in the
ZFYVE26 (612012) on 14q24; SPG18 (611225), caused by mutation in the ERLIN2 gene (611605)
on 8p11; SPG20 (275900), caused by mutation in the spartin gene (607111) on 13q12;
SPG21 (248900), caused by mutation in the maspardin gene (608181) on 15q21; SPG26
(609195), caused by mutation in the B4GALNT1 gene (601873) on 12q13; SPG28 (609340),
caused by mutation in the DDHD1 gene (614603) on 14q22; SPG30 (610357), caused by
mutation in the KIF1A gene (601255) on 2q37; SPG35 (612319), caused by mutation in
the FA2H gene (611026) on chromosome 16q23; SPG39 (612020), caused by mutation in
the;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the cytochrome P450, family 7, subfamily B, polypeptide 1 gene
(CYP7B1, 603711.0001);
Laboratory abnormalities : Increased plasma and CSF 27-hydroxycholesterol;
Prefixed ID : #270800;
Origin ID : 270800;
UMLS CUI : C1849115;
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)